China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD

3.97

+1.90 (91.79%)

At close: Dec 29, 2023, 4:00 PM

2.72

-1.25 (-31.49%)

After-hours: Dec 29, 2023, 7:59 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016
Revenue	0.03	0.34	0.88	0.33	0.21	1.32	0.73
Revenue Growth (YoY)	-90.09%	-61.68%	167.83%	55.75%	-83.89%	80.04%	-
Cost of Revenue	-1.55	-1.35	-1.94	-2.46	-2.4	-3.62	-2.57
Gross Profit	1.58	1.69	2.82	2.79	2.61	4.93	3.3
Selling, General & Admin	6.03	6.44	5.04	4.04	2.84	1.77	0.71
Operating Expenses	6.03	6.44	5.04	4.04	2.84	1.77	0.71
Operating Income	-4.45	-4.75	-2.21	-1.26	-0.23	3.17	2.59
Interest Expense / Income	0.48	0.04	1.62	3.35	0.01	0	0.04
Other Expense / Income	1	0.62	-0.89	5.78	-2.03	1.54	0.97
Pretax Income	-5.93	-5.41	-2.94	-10.39	1.79	1.63	1.58
Income Tax	0	0.33	-0.19	-0.1	0.25	0.44	0.4
Net Income	-5.93	-5.74	-2.75	-10.29	1.54	1.19	1.19
Net Income Growth	-	-	-	-	29.61%	0.21%	-
Shares Outstanding (Basic)	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0	0
Shares Change	541.90%	44.50%	132.79%	20.23%	2.84%	-	-
EPS (Basic)	-22.23	-137.93	-95.47	-832.05	149.50	118.00	118.00
EPS (Diluted)	-22.23	-137.93	-95.47	-832.05	149.50	118.00	118.00
EPS Growth	-	-	-	-	26.69%	0%	-
Free Cash Flow	-0.15	0.21	-1.41	0.53	-0.36	0.89	0.11
Free Cash Flow Per Share	-0.57	4.95	-48.98	42.67	-34.97	89.05	11.39
Gross Margin	4696.56%	498.27%	318.99%	844.05%	1231.48%	374.69%	451.26%
Operating Margin	-13249.91%	-1401.12%	-250.13%	-380.06%	-108.13%	240.35%	354.23%
Profit Margin	-17651.98%	-1691.43%	-310.53%	-3113.48%	725.52%	90.17%	162.01%
Free Cash Flow Margin	-450.44%	60.69%	-159.28%	159.67%	-169.51%	67.61%	15.57%
Effective Tax Rate	-	-	-	-	14.08%	27.04%	25.00%
EBITDA	-5.13	-5.05	-0.98	-6.71	1.98	1.76	1.72
EBITDA Margin	-15272.60%	-1489.49%	-110.74%	-2030.37%	932.13%	133.47%	235.11%
Depreciation & Amortization	0.32	0.32	0.35	0.33	0.18	0.13	0.1
EBIT	-5.46	-5.37	-1.33	-7.04	1.8	1.63	1.62
EBIT Margin	-16233.89%	-1583.85%	-149.77%	-2130.80%	846.85%	123.65%	221.54%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).